1. Home
  2. BLCO vs EPR Comparison

BLCO vs EPR Comparison

Compare BLCO & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.99

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$50.09

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
EPR
Founded
1853
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.4B
IPO Year
2022
1997

Fundamental Metrics

Financial Performance
Metric
BLCO
EPR
Price
$16.99
$50.09
Analyst Decision
Hold
Buy
Analyst Count
14
11
Target Price
$17.31
$57.06
AVG Volume (30 Days)
399.7K
609.7K
Earning Date
10-29-2025
10-29-2025
Dividend Yield
N/A
7.07%
EPS Growth
N/A
N/A
EPS
N/A
2.29
Revenue
$4,976,000,000.00
$707,150,000.00
Revenue This Year
$8.08
$5.11
Revenue Next Year
$5.77
$2.70
P/E Ratio
N/A
$21.91
Revenue Growth
6.23
3.73
52 Week Low
$10.45
$41.75
52 Week High
$18.99
$61.24

Technical Indicators

Market Signals
Indicator
BLCO
EPR
Relative Strength Index (RSI) 60.98 38.11
Support Level $16.39 $49.41
Resistance Level $17.41 $51.80
Average True Range (ATR) 0.46 0.94
MACD 0.06 -0.15
Stochastic Oscillator 72.71 20.14

Price Performance

Historical Comparison
BLCO
EPR

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

Share on Social Networks: